CSPG4 and melanoma: Proteomic profiling of melanoma-specific sEVs (CSPG4-captured) and non-malignant sEVs (non-captured) of 15 melanoma patients revealed 73 overexpressed proteins, of which 16 could discriminate melanoma-specific from non-malignant sEVs.